Author

Egor V. Shekunov

Russian Academy of SciencesORCID 0000-0002-9028-5112Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biophysics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Olga S. OstroumovaiD· 2 shared Svetlana S. EfimovaiD· 2 shared Alexander V. SlitaiD· 1 shared Anna A. Muryleva· 1 shared Elena T. AliperiD· 1 shared Pavel E. VolynskyiD· 1 shared Polina D. ZlodeevaiD· 1 shared Roman G. EfremoviD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

Olga S. OstroumovaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiophysicsbioRxivPreprintDec 11, 2024

Lipid specificity of action of SARS-CoV-2 fusion peptide fragments on model membranes

Egor V. Shekunov, Pavel E. Volynsky, Svetlana S. Efimova…·Olga S. Ostroumova

This study investigates how SARS-CoV-2 fusion peptide fragments interact with model membranes, showing the LLF motif's role in membrane fusion and how lipid composition affects fusogenic activity.

DOI 10.1101/2024.12.11.627892

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

Molecular BiologyAntiviral ResearchPeer-reviewedMar 2, 2023

Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: new tricks for old dogs

Egor V. Shekunov, Polina D. Zlodeeva, Svetlana S. Efimova…·Olga S. Ostroumova

The paper investigates the antiviral effects of cyclic lipopeptides against SARS-CoV-2 by assessing their ability to inhibit membrane fusion in vitro.

33 citationstop 2%

experimental assay

𝕏 PostBluesky